Indofarma Tbk
PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutic… Read more
Indofarma Tbk (INAF) - Total Liabilities
Latest total liabilities as of September 2025: Rp1.47 Trillion IDR
Based on the latest financial reports, Indofarma Tbk (INAF) has total liabilities worth Rp1.47 Trillion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Indofarma Tbk - Total Liabilities Trend (2000–2024)
This chart illustrates how Indofarma Tbk's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Indofarma Tbk Competitors by Total Liabilities
The table below lists competitors of Indofarma Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Spenda Ltd
AU:SPX
|
Australia | AU$13.22 Million |
|
More Return Public Company Limited
BK:MORE
|
Thailand | ฿68.72 Million |
|
TCI GENE Inc.
TWO:6879
|
Taiwan | NT$178.51 Million |
|
Carlo Rino Group Bhd
KLSE:0335
|
Malaysia | RM33.56 Million |
|
Shah Alloys Limited
NSE:SHAHALLOYS
|
India | ₹2.00 Billion |
|
Akora Resources Ltd
AU:AKO
|
Australia | AU$296.45K |
|
Stavely Minerals Ltd
AU:SVY
|
Australia | AU$732.40K |
Liability Composition Analysis (2000–2024)
This chart breaks down Indofarma Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indofarma Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indofarma Tbk (2000–2024)
The table below shows the annual total liabilities of Indofarma Tbk from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.76 Trillion | +12.67% |
| 2023-12-31 | Rp1.56 Trillion | +8.04% |
| 2022-12-31 | Rp1.45 Trillion | -3.72% |
| 2021-12-31 | Rp1.50 Trillion | +17.19% |
| 2020-12-31 | Rp1.28 Trillion | +45.96% |
| 2019-12-31 | Rp879.00 Billion | -7.05% |
| 2018-12-31 | Rp945.70 Billion | -5.76% |
| 2017-12-31 | Rp1.00 Trillion | +24.52% |
| 2016-12-31 | Rp805.88 Billion | -14.36% |
| 2015-12-31 | Rp941.00 Billion | +43.36% |
| 2014-12-31 | Rp656.38 Billion | -6.73% |
| 2013-12-31 | Rp703.72 Billion | +30.68% |
| 2012-12-31 | Rp538.52 Billion | +6.49% |
| 2011-12-31 | Rp505.71 Billion | +19.64% |
| 2010-12-31 | Rp422.69 Billion | -1.54% |
| 2009-12-31 | Rp429.31 Billion | -35.85% |
| 2008-12-31 | Rp669.22 Billion | -6.78% |
| 2007-12-31 | Rp717.87 Billion | +76.62% |
| 2006-12-31 | Rp406.45 Billion | +60.29% |
| 2005-12-31 | Rp253.58 Billion | -5.47% |
| 2004-12-31 | Rp268.26 Billion | -27.11% |
| 2003-12-31 | Rp368.02 Billion | -10.68% |
| 2002-12-31 | Rp412.04 Billion | +40.06% |
| 2001-12-31 | Rp294.19 Billion | +19.78% |
| 2000-12-31 | Rp245.61 Billion | -- |